Wegovy-like hormone aids weight loss

This is a Ozempic news story, published by Gizmodo, that relates primarily to Stanford Medicine news.

Ozempic news

For more Ozempic news, you can click here:

more Ozempic news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Gizmodo news

For more news from Gizmodo, you can click here:

more news from Gizmodo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

obesity medicine

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obese mice news, greater weight loss news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

obesity treatment

Gizmodo

•

Health

Stanford researchers say they've discovered a naturally occurring hormone that might help people lose weight while avoiding the side effects of Ozempic and Wegovy

Summary

Nutrition label

73% Informative

Stanford Medicine researchers say they’ve discovered a naturally occurring hormone that might help people lose weight while avoiding the side effects commonly associated with semaglutide (the active ingredient in Ozempic and Wegovy) and similar drugs.

With the help of artificial intelligence, the team identified a previously unknown peptide that appeared to safely reduce the appetite and weight of mice and miniature pigs without causing nausea or other gastrointestinal symptoms.

For their part, Svensson and her colleagues have already filed patents on BRP , and she has co-founded a company that she hopes will develop the molecule for clinical use. No drug comes without side effects, but the future of obesity treatment could someday involve a lot less nausea..

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful